CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangioc
- This topic has 0 replies, 1 voice, and was last updated 6 years, 10 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.
https://www.ncbi.nlm.nih.gov/pubmed/28883618
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.